A Phase IIa trial of BC007
Phase of Trial: Phase II/III
Latest Information Update: 23 May 2018
At a glance
- Drugs BC 007 (Primary)
- Indications Dilated cardiomyopathy
- Focus Adverse reactions; Therapeutic Use
- 23 May 2018 According to a Berlin Cures media release, this study will begin this July 2018.
- 05 Mar 2018 New trial record
- 26 Feb 2018 According to a Berlin Cures media release, Company plans to begin Phase II clinical testing of BC007 in the second quarter of 2018.